Hirofumi Nakaoka

The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice

Aisha Yesbolatova, Yuichiro Saito, Naomi Kitamoto et al. · Nature Communications · 2020 · 574 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +7

Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium

Kazuaki Suda, Hirofumi Nakaoka, Kosuke Yoshihara et al. · Cell Reports · 2018 · 414 citations · Full text

Medicine, Genetics, Oncology +8

Systematic identification and characterization of regulatory elements derived from human endogenous retroviruses

Ryota Sugimoto, Hirofumi Nakaoka, Shiro YAMADA et al. · PLoS Genetics · 2017 · 192 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes

Hirotaka Matsuo, Ken Yamamoto, Hirofumi Nakaoka et al. · Annals of the Rheumatic Diseases · 2015 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload

Hirotaka Matsuo, Akiyoshi Nakayama, Masayuki Sakiyama et al. · Scientific Reports · 2014 · 163 citations · Full text

Medicine, Nephrology, Physiology +8